21 mayo 2015
Almost 90 percent of men with advanced prostate cancer carry genetic mutations in their tumors that could be targeted by either existing or new cancer drugs, a landmark new study reveals. Scientists now have created a comprehensive map of the genetic mutations within lethal prostate cancers that have spread around the body, in a paper being hailed as the disease’s ‘Rosetta Stone.’
http://feeds.sciencedaily.com/~r/sciencedaily/~3/vtidDfnIdvg/150521133732.htm
